These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 5494580
1. Immunological and pathological manifestations of murine sarcoma virus (Moloney) infections. Schlom J, Moloney JB, Groupé V. Cancer Res; 1970 Dec; 30(12):2955-61. PubMed ID: 5494580 [No Abstract] [Full Text] [Related]
2. Senescent loss of resistance to murine sarcoma virus (Moloney) in the mouse. Pazmiño NH, Yuhas JM. Cancer Res; 1973 Nov; 33(11):2668-72. PubMed ID: 4748428 [No Abstract] [Full Text] [Related]
3. Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumors in mice. Fefer A, McCoy JL, Perk K, Glynn JP. Cancer Res; 1968 Aug; 28(8):1577-85. PubMed ID: 4876979 [No Abstract] [Full Text] [Related]
4. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma. Pearson GR, Redmon LW, Bass LR. Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119 [No Abstract] [Full Text] [Related]
5. Serochemotherapy against a Moloney virus-induced leukemia. Pearson GR, Redmon LW, Pearson JW. Cancer Res; 1973 Aug; 33(8):1854-7. PubMed ID: 4578564 [No Abstract] [Full Text] [Related]
6. Immunization with p30 enhances the growth of a rat Moloney sarcoma. Jones JM, Kennel SJ, Feldman JD. J Immunol; 1977 Jan; 118(1):371-3. PubMed ID: 830759 [No Abstract] [Full Text] [Related]
7. Induction and regression of primary moloney sarcoma virus-induced tumors in mice. Fefer A, McCoy JL, Glynn JP. Cancer Res; 1967 Sep; 27(9):1626-31. PubMed ID: 4860892 [No Abstract] [Full Text] [Related]
8. Increased oncogenicity of the murine sarcoma virus (Moloney) by co-infection with murine leukemia viruses. Chirigos MA, Perk K, Turner W, Burka B, Gomez M. Cancer Res; 1968 Jun; 28(6):1055-63. PubMed ID: 5658439 [No Abstract] [Full Text] [Related]
9. Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice. Fefer A. Cancer Res; 1969 Dec; 29(12):2177-83. PubMed ID: 5369675 [No Abstract] [Full Text] [Related]
10. Antigenicity of a virus-induced murine sarcoma (Moloney). Fefer A, McCoy JL, Glynn JP. Cancer Res; 1967 May; 27(5):962-7. PubMed ID: 4290556 [No Abstract] [Full Text] [Related]
11. Application of antisera to interferon in studying oncogenic viruses. Inglot AD, Oleszak E. Arch Immunol Ther Exp (Warsz); 1978 May; 26(1-6):529-36. PubMed ID: 219809 [Abstract] [Full Text] [Related]
12. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors. Collavo D, Ronchese F, Zanovello P, Biasi G, Chieco-Bianchi L. J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385 [No Abstract] [Full Text] [Related]
15. Protection by immune spleen cells against challenge with Moloney sarcoma virus. Effect of stage of donor response. Pollack S, Nelson K. Transplantation; 1973 May; 15(5):510-3. PubMed ID: 4710486 [No Abstract] [Full Text] [Related]